Table 1.
Approach | Method | Use | Features |
---|---|---|---|
Direct detection | Dark ground microscopy PCR |
Require exudates and fluids from lesions PCR improving diagnostic thresholds |
|
Treponemal tests | EIA TPHA/TPPA Western blot (IgG or IgM) |
Screening | Highly sensitive Do not correlate with disease activity |
Non-treponemal tests (against anti-cardiolipin antibodies) | VDRL RPR |
Monitor treatment response Qualitative titre |
Correlate with disease activity and treatment response Risk of false positive results |
EIA enzyme immunoassay, IgG immunoglobulin G, IgM immunoglobulin M, PCR polymerase chain reaction, TPHA Treponema pallidum haemagglutination assay, TPPA Treponema pallidum particle agglutination assay, RPR rapid plasma reagin, VDRL venereal disease research laboratory